U.S. FDA gives early approval to Sarepta's newest DMD treatment

U.S. FDA gives early approval to Sarepta's newest DMD treatment
Reuters: Health
The U.S. Food and Drug Administration on Thursday granted an early approval to Sarepta Therapeutics Inc's second treatment for Duchenne muscular dystrophy (DMD).